DATROWAY® EU Approval for Metastatic TNBC Treatment
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus...
Tag : European Medicines Agency
Novo Nordisk: New Wegovy® Dose Helps Achieve 20.7% Weight Loss
Today, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for a higher dose of Wegovy® (semaglutide 7.2...
Sirius Therapeutics Raises $50M for siRNA Cardiometabolic Therapy
Sirius Therapeutics today announced that it has successfully completed nearly $50 million Series B2 financing to advance clinical development of the Company’s novel siRNA therapeutics...
Bristol Myers Squibb Gets CHMP Opinion for Breyanzi in Lymphoma
Recommendation based on the Phase 2 TRANSCEND FL study in which 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving complete response Across clinical...